200 related articles for article (PubMed ID: 8972034)
1. Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity.
Fuse I; Hattori A; Mito M; Higuchi W; Yahata K; Shibata A; Aizawa Y
Thromb Haemost; 1996 Dec; 76(6):1080-5. PubMed ID: 8972034
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity.
Higuchi W; Fuse I; Hattori A; Aizawa Y
Thromb Haemost; 1999 Nov; 82(5):1528-31. PubMed ID: 10595649
[TBL] [Abstract][Full Text] [Related]
3. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of a dominantly inherited bleeding disorder with impaired platelet responses to thromboxane A2.
Okuma M; Hirata T; Ushikubi F; Kakizuka A; Narumiya S
Pol J Pharmacol; 1996; 48(1):77-82. PubMed ID: 9112632
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic thrombocytopathy with platelet thromboxane A2 receptor abnormality: defective signal transduction with normal binding activity.
Ushikubi F; Okuma M; Kanaji K; Sugiyama T; Ogorochi T; Narumiya S; Uchino H
Thromb Haemost; 1987 Apr; 57(2):158-64. PubMed ID: 2955539
[TBL] [Abstract][Full Text] [Related]
6. Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.
Fuse I; Mito M; Hattori A; Higuchi W; Shibata A; Ushikubi F; Okuma M; Yahata K
Blood; 1993 Feb; 81(4):994-1000. PubMed ID: 8428006
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the defective signal transduction mechanism through the platelet thromboxane A2 receptor in a patient with polycythemia vera.
Ushikubi F; Ishibashi T; Narumiya S; Okuma M
Thromb Haemost; 1992 Jan; 67(1):144-6. PubMed ID: 1535462
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of a bleeding disorder characterized by platelet unresponsiveness to thromboxane A2.
Fuse I; Higuchi W; Aizawa Y
Semin Thromb Hemost; 2000; 26(1):43-5. PubMed ID: 10805281
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity to thromboxane A2 in cholesterol-rich human platelets.
Tomizuka T; Yamamoto K; Hirai A; Tamura Y; Yoshida S
Thromb Haemost; 1990 Dec; 64(4):594-9. PubMed ID: 2150728
[TBL] [Abstract][Full Text] [Related]
11. [PI metabolism and Ca mobilization in patients with platelet dysfunction].
Fuse I; Hattori A; Higuchi W; Shibata A
Nihon Rinsho; 1992 Feb; 50(2):237-43. PubMed ID: 1535386
[TBL] [Abstract][Full Text] [Related]
12. Castration reduces platelet thromboxane A2 receptor density and aggregability.
Ajayi AA; Halushka PV
QJM; 2005 May; 98(5):349-56. PubMed ID: 15820970
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of platelet shape change, inositol metabolism, and Ca mobilization in patients with platelet dysfunction].
Fuse I; Hattori A; Higuchi W
Rinsho Byori; 1992 Mar; 40(3):287-96. PubMed ID: 1518180
[TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
[TBL] [Abstract][Full Text] [Related]
16. [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome].
Watanabe M; Suzuki J; Suzuki H
Nihon Jinzo Gakkai Shi; 1996 Aug; 38(8):356-63. PubMed ID: 8828355
[TBL] [Abstract][Full Text] [Related]
17. Constitutional thrombocytopathy with subnormal response to thromboxane A2.
Samama M; Lecrubier C; Conard J; Hotchen M; Breton-Gorius J; Vargaftig B; Chignard M; Lagarde M; Dechavanne M
Br J Haematol; 1981 Jun; 48(2):293-303. PubMed ID: 7195274
[TBL] [Abstract][Full Text] [Related]
18. Characterization of platelet cytoplasmic Ca2+ mobilization in patients with congenital cyclo-oxygenase deficiency and with defective platelet aggregation to A23187.
Fuse I; Hattori A; Nagayama R
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1522-33. PubMed ID: 2516953
[TBL] [Abstract][Full Text] [Related]
19. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation.
Hirata T; Ushikubi F; Kakizuka A; Okuma M; Narumiya S
J Clin Invest; 1996 Feb; 97(4):949-56. PubMed ID: 8613548
[TBL] [Abstract][Full Text] [Related]
20. Impaired platelet response to thromboxane-A2 and defective calcium mobilization in a patient with a bleeding disorder.
Lages B; Malmsten C; Weiss HJ; Samuelsson B
Blood; 1981 Mar; 57(3):545-52. PubMed ID: 7459434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
